Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11175279rdf:typepubmed:Citationlld:pubmed
pubmed-article:11175279lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:11175279lifeskim:mentionsumls-concept:C0752125lld:lifeskim
pubmed-article:11175279lifeskim:mentionsumls-concept:C0036273lld:lifeskim
pubmed-article:11175279lifeskim:mentionsumls-concept:C0205214lld:lifeskim
pubmed-article:11175279lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:11175279pubmed:issue12lld:pubmed
pubmed-article:11175279pubmed:dateCreated2001-1-22lld:pubmed
pubmed-article:11175279pubmed:abstractTextSpinocerebellar ataxia type 7 (SCA7) is a neuro-degenerative disorder characterised by progressive cerebellar ataxia and macular degeneration. SCA7 is one of the least common genetically verified autosomal dominant cerebellar ataxias (ADCAs) in the world (4.5 to 11.6%), but in Sweden and Finland SCA7 is the most commonly identified form of ADCA. In an inventory of hereditary ataxias in Scandinavia (Sweden, Norway, Denmark and Finland) we identified 15 SCA7 families, eight in Sweden and seven in Finland, while no cases of SCA7 could be found in Norway or Denmark. We examined whether the relatively high frequency of SCA7 families in Sweden and Finland was the result of a common founder effect. Only two out of 15 families could be connected genealogically. However, an extensive haplotype analysis over a 10.2 cM region surrounding the SCA7 gene locus showed that all 15 families studied shared a common haplotype over at least 1.9 cM. This strongly suggests that all Scandinavian SCA7 families originate from a common founder pre-mutation.lld:pubmed
pubmed-article:11175279pubmed:languageenglld:pubmed
pubmed-article:11175279pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11175279pubmed:citationSubsetIMlld:pubmed
pubmed-article:11175279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11175279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11175279pubmed:statusMEDLINElld:pubmed
pubmed-article:11175279pubmed:monthDeclld:pubmed
pubmed-article:11175279pubmed:issn1018-4813lld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:WahlströmJJlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:JonassonJJlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:HolmgrenGGlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:HolmbergMMlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:SistonenPPlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:IgnatiusJJlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:JohanssonDDlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:ForsgrenLLlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:MelbergAAlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:JuvonenVVlld:pubmed
pubmed-article:11175279pubmed:authorpubmed-author:BjörckE JEJlld:pubmed
pubmed-article:11175279pubmed:issnTypePrintlld:pubmed
pubmed-article:11175279pubmed:volume8lld:pubmed
pubmed-article:11175279pubmed:ownerNLMlld:pubmed
pubmed-article:11175279pubmed:authorsCompleteYlld:pubmed
pubmed-article:11175279pubmed:pagination918-22lld:pubmed
pubmed-article:11175279pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:meshHeadingpubmed-meshheading:11175279...lld:pubmed
pubmed-article:11175279pubmed:year2000lld:pubmed
pubmed-article:11175279pubmed:articleTitleEvidence for a common Spinocerebellar ataxia type 7 (SCA7) founder mutation in Scandinavia.lld:pubmed
pubmed-article:11175279pubmed:affiliationDepartment of Microbiology, Umeå University, Sweden.lld:pubmed
pubmed-article:11175279pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11175279pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed